- Report
- March 2022
Global
From €4689EUR$4,850USD£4,030GBP
From €725EUR$750USD£623GBP
- Report
- August 2023
Japan, United States, ... Japan, United States, Europe
From €1402EUR$1,450USD£1,205GBP
- Report
- July 2022
- 132 Pages
Global
From €822EUR$850USD£706GBP
- Report
- November 2018
- 77 Pages
Global
€4834EUR$5,000USD£4,155GBP
- Report
- April 2021
- 220 Pages
Global
From €5963EUR$6,168USD£5,125GBP
- Report
- September 2023
- 140 Pages
Global
From €2899EUR$2,999USD£2,492GBP
The Cannabis Testing market is a subset of the Drug Abuse Screening market, which is focused on the detection of illicit drugs in biological samples. Cannabis Testing is used to detect the presence of cannabinoids, such as THC and CBD, in biological samples. This type of testing is used to identify individuals who are using cannabis for recreational or medical purposes, as well as to detect individuals who are using cannabis illegally. Cannabis Testing is also used to monitor the potency of cannabis products, as well as to detect the presence of contaminants, such as pesticides and heavy metals.
Cannabis Testing is typically performed using a variety of analytical techniques, such as gas chromatography, mass spectrometry, and immunoassays. These techniques are used to detect the presence of cannabinoids, as well as to measure the concentration of cannabinoids in a sample.
Some companies in the Cannabis Testing market include Agilent Technologies, Shimadzu Corporation, Thermo Fisher Scientific, PerkinElmer, and Waters Corporation. Show Less Read more
